Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$32.06 USD
-0.40 (-1.23%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $32.05 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.06 USD
-0.40 (-1.23%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $32.05 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Zacks News
Koninklijke Philips Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Koninklijke Philips has been struggling lately, but the selling pressure may be coming to an end soon.
PHG vs. TRMB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PHG vs. TRMB: Which Stock Is the Better Value Option?
PHG vs. GRMN: Which Stock Is the Better Value Option?
by Zacks Equity Research
PHG vs. GRMN: Which Stock Is the Better Value Option?
Philips (PHG) Q1 Earnings Up on Solid Sales, China Growth
by Aniruddha Ganguly
Philips' (PHG) first-quarter 2019 results benefit from higher sales from Personal Health and Diagnosis & Treatment businesses.
Trimble's Tekla PowerFab Expands Steel Fabrication Portfolio
by Zacks Equity Research
Trimble (TRMB) rolls out a steel fabrication software solution - Tekla PowerFab - that offers real-time information to all project parties.
Scientific Games (SGMS) Q4 Earnings & Revenues Rise Y/Y
by Zacks Equity Research
Scientific Games (SGMS) fourth-quarter 2018 results benefit from robust performance of Lottery and Social segment but higher restructuring expenses hurt.
PHG or GRMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PHG vs. GRMN: Which Stock Is the Better Value Option?
Trade Desk (TTD) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Trade Desk's (TTD) fourth-quarter 2018 results benefit from growth in CTV, strong customer retention and expanding international presence.
PHG or GRMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PHG vs. GRMN: Which Stock Is the Better Value Option?
New Strong Buy Stocks for February 6th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips
Top Stock Reports for Pfizer, Biogen & Schwab
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Biogen (BIIB) and Schwab (SCHW).
Philips (PHG) Expands Personal Health Portfolio at CES 2019
by Zacks Equity Research
Philips' (PHG) new offerings at CES 2019 include sleep, oral and personal care solutions.
Koninklijke Philips' (PHG) Q3 Sales Up Y/Y, Earnings Down
by Zacks Equity Research
Koninklijke Philips' (PHG) third-quarter 2018 earnings benefits from the strong growth in Diagnosis & Treatment segment.
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
Top Analyst Reports for AstraZeneca, Salesforce & Mastercard
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including AstraZeneca (AZN), salesforce.com (CRM) and Mastercard (MA)
Philips Evolves as a Healthcare Company, Tariffs a Concern
by Zacks Equity Research
Koninklijke Philips (PHG) is gaining solid momentum as it further penetrates the healthcare market.
DKILY vs. PHG: Which Stock Is the Better Value Option?
by Zacks Equity Research
DKILY vs. PHG: Which Stock Is the Better Value Option?
Koninklijke Philips' (PHG) Q2 Earnings Up Y/Y, Sales Flat
by Zacks Equity Research
Koninklijke Philips' (PHG) second-quarter results benefit from robust performance in the Diagnosis & Treatment business.
Stock Market News For Jul 2, 2018
by Zacks Equity Research
Markets closed higher on Friday, the last trading session of the first half of the year, as energy stocks rallied.
LabCorp, Philips Tie Up to Advance in Digital Pathology
by Zacks Equity Research
Through the latest collaboration, LabCorp (LH) aims at strengthening its hold inthe high potential digital pathology market.
PHG vs. TRMB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PHG vs. TRMB: Which Stock Is the Better Value Option?
Philips EPD Buyout to Expand Image-Guided Therapy Portfolio
by Zacks Equity Research
Koninklijke Philips (PHG) is set to buy cardiac imaging and navigation system provider EPD solutions.
Philips (PHG) Reports Q1 Earnings, Comparable Order Intake Up
by Zacks Equity Research
Phillips' (PHG) first-quarter 2018 results benefit from its Diagnosis & Treatment businesses on the back of growth in Ultrasound, Diagnostic Imaging and Image-Guided Therapy.
Philips' Dual Use DRF System Gets FDA Nod for Marketing
by Zacks Equity Research
Koninklijke Philips's (PHG) new Digital Radiography-Fluoroscopy system receives approval of the U.S. Food and Drug Administration for marketing.